| US 7,524,830 B2 | ||
| Decoy-containing pharmaceutical compositions and method of using the same | ||
| Ryuichi Morishita, Osaka (Japan); Motokuni Aoki, Osaka (Japan); Toshio Ogihara, Osaka (Japan); and Tomio Kawasaki, Osaka (Japan) | ||
| Assigned to AnGes MG, Inc., Osaka (Japan) | ||
| Filed on Oct. 12, 2006, as Appl. No. 11/580,748. | ||
| Application 11/580748 is a continuation of application No. 10/466239, abandoned, previously published as PCT/JP02/00865, filed on Feb. 01, 2002. | ||
| Prior Publication US 2007/0142314 A1, Jun. 21, 2007 | ||
| Int. Cl. A61K 31/70 (2006.01); C07H 21/02 (2006.01); C07H 21/04 (2006.01); C12Q 1/68 (2006.01) | ||
| U.S. Cl. 514—44 [536/23.1; 536/24.1; 536/24.5; 435/6] | 3 Claims |
| 1. A method for treating a disease selected from the group consisting of aneurysm, Marfan's syndrome, and aortic detachment;
wherein said method comprises administering a composition comprising at least one oligonucleotide decoy, selected from the
group consisting of an ets decoy and a chimera decoy of NF-κB and ets;
and a pharmaceutically acceptable carrier.
|